This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

ATTAIN-2 Trial: Oral GLP-1 Orforglipron Lowers Weight and HbA1c among diabetics with obesity

ATTAIN-2 Trial: Oral GLP-1 Orforglipron Lowers Weight and HbA1c among diabetics with obesity

Topline results from the ATTAIN-2 trial have demonstrated that adults taking 36 mg orforglipron lost an average of 10.5% body weight at 72 weeks,...
View All

Latest News and Guidelines

Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials

Nitazoxanide Reduces Oxidative Stress and Inflammation in Type 2 Diabetes Without Affecting Glycemic...

Type 2 diabetes blood factors drive breast cancer aggression, finds BU study

Type 2 diabetes blood factors drive breast cancer aggression, finds BU study

Proactive Consideration of Metformin in Prediabetes-A Call of Action

Proactive Consideration of Metformin in Prediabetes-A Call of Action

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

Biocon Pharma bags tentative USFDA nod for diabetes medicine Sitagliptin

High Coronary Artery Calcium in Type 1 Diabetes Patients Despite Good Control, Study Finds

High Coronary Artery Calcium in Type 1 Diabetes Patients Despite Good Control, Study Finds

Mediterranean Diet Combined With Lifestyle Changes May Lower Diabetes Risk By 31 Percent: Study Shows

Mediterranean Diet Combined With Lifestyle Changes May Lower Diabetes Risk By 31 Percent: Study...

View All
X